Case Report  http://dx.doi.org/10.3126/njdvl.v16i1.19418

Pyoderma Gangrenosum with Positive Antinuclear Antibody, in the Absence of Systemic Association

Shrestha S1, Aryal A2

1Lecturer, 2Second Year Resident, Department of Dermatology, Dhulikhel Hospital, Kathmandu University-Teaching Hospital, Dhulikhel, Kavre, Nepal.

Abstract gangrenosum is an uncommon neutrophilic dermatosis, seen on legs, and infrequently on hands and other anatomical sites. It is associated with systemic diseases in 50-70% of the cases. Antinuclear antibody (ANA) seropositivity has been reported in pyoderma gangrenosum associated with connective tissue disorders. However, there are very few case reports of pyoderma gangrenosum in patients of systemic , while we did not find any reports of ANA seropositivity in isolated pyoderma gangrenosum. Hence, we report this unique case of pyoderma gangrenosum with classical clinicohistopathology, positive ANA but no systemic association. As anticipated, our patient responded promptly to steroids. Key words: Antibodies; connective tissue diseases; lupus erythematosus; , leukocytoclastic

Introduction systemic comorbidi es were elicited from history. She was a nonsmoker. yoderma gangrenosum (PG) is a rare necro zing, Pulcera ve neutrophilic dermatosis.1 It is usually On examina on, pa ent was afebrile with normal associated with various systemic illnesses, but vital signs (BP 100/60 mm of mercury, Pulse 84/m, rarely described in associa on with systemic lupus RR 18/min). Cutaneous examina on revealed fi ve erythematosus (SLE) or an nuclear an body (ANA) annular lesions on sun-exposed sites of hands and seroposi vity. We report this case of PG on sunexposed feet (Figure 1). Among them, only one lesion on right sites, with posi ve ANA and no internal disease. hand was vegeta ve. Others were ulcera ve plaques of varying sizes, with undermined edges, irregular Case Report border, containing hemorrhagic and necro c slough and a conspicuous edematous violaceous margin. A 61 years old lady, presented to Dermatology OPD, Largest plaque had dimensions of 6×5 cm. Head to with complaint of mul ple painful ulcers on dorsa toe examina on and systemic fi ndings were normal. of bilateral hands and feet for seven days. Ini ally, Pathergy test was nega ve. there were mul ple, asymptoma c, erythematous papules on hands and feet, that rapidly evolved into large ulcera ve plaques. Pa ent did not no ce any Submitted: 5th January 2018 cons tu onal symptoms during progression of lesions. Accepted: 18th February 2018 She had no prior history of trauma, insect bite, topical Published: 21st March 2018 applica on or drug intake. There was no fever, joint pain, morning s ff ness, diarrhea, cons pa on, pain How to cite this article abdomen, blood in stool, weight loss or decreased Shrestha S, Aryal A. Pyoderma gangrenosum with positive appe te. Pa ent did not have oral ulcers, malar rash, antinuclear antibody, in the absence of systemic association. hair loss, menstrual irregularity or headache. No Nepal Journal of Dermatology Venereology and Leprology. 2018;16(1):66-9. doi: http://dx.doi.org/10.3126/njdvl.v16i1.19418

Address of Correspondence: Dr. Smriti Shrestha Dhulikhel Hospital, Kathmandu University-Teaching Hospital, Licensed under CC BY 4.0 International License which permits Dhulikhel, Kavre, Nepal. use, distribution and reproduction in any medium, provided E-mail: [email protected] the original work is properly cited.

66 

Blood tests and rou ne inves ga ons were sent. There abdominal ultrasonography and colonoscopy were was mild leukocytosis of 10,300×109/L (reference normal. interval 4.0×09−11.0×109/L) with neutrophilia (82%), and elevated acute phase reactants, ESR 44mm/hr Histopathology confi rmed our provisional diagnosis, (reference interval 0-20 mm/hour) and CRP 31μg/ showing epidermal intracorneal neutrophilic ml (reference interval 0-5μg/ml). Peripheral smear collec ons with areas of necrosis and extensive dermal showed shi to le with neutrophilia, toxic granules neutrophilic infi ltrates with vasculopathy (Figure 2). and RBC polychromatophils. An nuclear an body was raised as 3.1 (reference interval 0.5-1.0 IU) However, Oral steroids () was started upon inves ga ons done for blood sugar, liver func on, admission. Normal saline and vaseline gauze dressing renal parameters, urine and stool rou ne, stool for was done twice a day for 3 days. Skin lesions showed occult blood, rheumatoid factor, an -ds DNA, serum drama c improvement with steroids within 48 hours complement, thyroid profi le, wound swab culture, (Figure 3). Pa ent was kept on hydroxychloroqine as maintenance therapy. There was no relapse un l two months of discon nua on of therapy ( ll date).

Figure 1: Large ulceronecro c lesions with edematous violaceous border on dorsa of hands and feet. Single vegeta ve lesion on dorsum of right hand

2a 2b Figure 2a, 2b: Hematoxylin and Eosin stain: 2a (4x), 2b (10x) photomicrograph showing epidermal , irregular acanthosis and spongiosis with foci of intracorneal neutrophilic collec ons and areas of necrosis. Papillary dermis shows extensive neutrophilic infi ltra on forming , with fragmented , suppura ve necrosis, hemorrhage and endothelial swelling. Lower dermis has mixed infi ltrates of perivascular and periadnexal neutrophils and lymphocytes. No evidence of leukocytoclas c vasculi s.

67 NJDVL. Vol 16, No.1, 2018 

Figure 3: Clinical improvement on Day 2 and Day 4 of star ng treatment.

Discussion infi ltrates seen in PG, without vasculi s and , has been called “sea of neutrophils.”1 Pyoderma gangrenosum (PG) is a painful, non- infec ous, rapidly spreading, necro zing skin In 2004, Su WP et al proposed a diagnos c criterion ulcera on, regarded as a spectrum of neutrophilic of PG.5 It encompassed characteris c clinical dermatosis.1 It was fi rst described in 1908 by French and histological fi ndings, in associa on with systemic dermatologist Brocq as “geometric phagedenism”, illnesses, a er excluding other causes of cutaneous and later Bruns ng et al renamed it as “pyoderma ulcera on. Resistance to an bio cs and surgical gangrenosum” as he believed that it occurred therapy and improvement with steroids is dis nc ve.7 secondary to bacterial infec on.2,3 In our pa ent, there were classical lesions of PG on sun-exposed sites, that responded eff ec vely to It is an uncommon reac ve phenomenon, with 3–10 steroids. Diagnosis of PG was made a er exclusion of new cases per million popula on yearly.4 It usually other causes of cutaneous ulcer. Seroposi vity for ANA aff ects adults between 20-50 years and rarely children. without manifesta ons of SLE or any other systemic Around 50–70% cases have systemic associa on, disease is unprecedented. observed commonly with infl ammatory bowel disease, rheumatoid arthri s and hematologic malignancy. It is ANA is regarded as a marker of systemic autoimmune also seen in surgical wound sites and at sites of trauma, connec ve ssue disorder. Although it is highly (95%) known as pathergy, which occurs in 25-30% of PG.1,4 sensi ve for SLE, it is not a specifi c marker. Posi ve predic ve value of ANA in SLE in 11-49% and much There are four clinical forms of PG described as lower in other connec ve ssue disorders (CTD).9 On ulcera ve, bullous, pustular and vegeta ve lesions. the other hand, ANA is also observed in 5% of healthy Various clinical subtypes have dis nct systemic individuals.10 Likewise, although SLE is common associa on. It begins as infl ammatory papule, nodule among women of reproduc ve age group, pyoderma or pustule, which swi ly develops into undermined gangrenosum is a rare en ty. Associa on of PG and ulcero-necrosis with characteris c violaceous border.1 SLE is rela vely recent and sparse.11 Waldman MA et al It heals with descrip ve cribiform “cigare e paper- reported an interes ng case where PG preceded onset like” .5 Lesions occur in leg in 70% cases, less of SLE by 8 years.12 This should be noted as PG might be common on face, neck, hands, trunks, breast, genitalia a harbinger of chronic autoimmunity. At the other end and rarely at extracutaneous ssues.6,7 We did not fi nd of the fringe, pa ent with chronic SLE has developed pyoderma gangrenosum reported on sun-exposed PG lesions.13 Hence the temporal rela onship between sites. two diseases has been variable. In our case scenario, presence of PG lesions in a female with ANA reac vity Histopathology of early lesion from advancing border suggests possibility of connec ve ssue disorder in shows infl ammatory infi ltrates in dermis, with or future. However, since ANA is also observed in healthy without leukocytoclas c vasculi s. Ulcera on of individuals, and this fi nding could be coincidental in the tends to be secondary to the dermal isolated PG. With further studies, the associa on of infl amma on. Older lesion with ulcera on shows SLE and ANA with PG might be extrapolated in future. neutrophilic infi ltrates in epidermis and dermis, without infec ous agents.8 Diff use dermal neutrophilic The mainstay of treatment is steroids, although there

NJDVL. Vol 16, No.1, 2018 68  are no standard guidelines yet. Steroid sparing immune associa on, we have described this en ty. We did modifi ers used in PG are azathioprine, cyclosporine, not fi nd any evidence of connec ve ssue disorder in cyclophosphamide, mycophenolate mofe l, biologics our pa ent, but have discussed previous associa ons. and intravenous immunotherapy.1,3,6 Further studies might validate the rela on of PG with SLE, as well as its dynamics with ANA serology. Conclusion Financial disclosure: None. Given the rarity of pyoderma gangrenosum, and no Confl icts of interest to disclosure: None declared. previous reports of ANA reac vity without systemic

References study of pyoderma gangrenosum. J Cutan Pathol. 1986;13(5):323-30. h ps://doi. 1. Bhat RM. Pyoderma gangrenosum: An update. org/10.1111/j.1600-0560.1986.tb00466.x Indian Dermatol Online J. 2012;3(1):7-13. h ps://doi.org/10.4103/2229-5178.93482 9. Soto ME, Hernandez-Becerril N, Perez-Chiney AC, Hernandez-Rizo A, Telich-Tarriba JE, Juarez- 2. Brocq L. A new contribu on to the study Orozco Le, et al. Predic ve value of an nuclear of geometric phagedenism. Ann Dermatol an bodies in autoimmune diseases classifi ed Syphiligr. 1916;9:1–39. by clinical criteria: Analy cal study in a 3. Bhat RM, Nandakishore B, Sequeira FF, Sukumar specialized health ins tute, one year follow- D, Kamath GH, Mar s J, et al. Pyoderma up. Results Immunol. 2015;5:13-22. h ps://doi. gangrenosum: An Indian perspec ve. Clin org/10.1016/j.rinim.2013.10.003 Exp Dermatol. 2011;36:242-7. h ps://doi. 10. Satoh M, Mercado MV-D, Chan EKL. Clinical org/10.1111/j.1365-2230.2010.03941.x interpreta on of an nuclear an body tests 4. Wollina U. Pyoderma gangrenosum – a review. in systemic rheuma c diseases. J Modern Orphanet J Rare Dis. 2007;2:19. h ps://doi. Rheumatol. 2009;19(3):219-28. h ps://doi. org/10.1186/1750-1172-2-19 org/10.3109/s10165-009-0155-3 5. Su WP, Davis MD, Weenig RH, Powell FC, Perry 11. González-Moreno J, Ruíz-Ruigomez M, Callejas HO. Int J Dermatol. 2004;43(11):790-800. h ps:// Rubio JL, Ríos Fernández R, Ortego Centeno N. doi.org/10.1111/j.1365-4632.2004.02128.x Pyoderma gangrenosum and systemic lupus 6. Satoh M, Yamamoto T. Genital pyoderma erythematosus: a report of fi ve cases and review gangrenosum: report of two cases and of the literature. Lupus. 2015;24(2):130-7. published work review of Japanese cases. J h ps://doi.org/10.1177/0961203314550227 Dermatol. 2013;40(10):840-3. h ps://doi. 12. Waldman MA, Callen JP. Pyoderma gangrenosum org/10.1111/1346-8138.12252 preceding the diagnosis of systemic lupus 7. Marinopoulos S, Theofanakis C, Zacharouli erythematosus. Dermatol. 2005;210(1):64-7. T, So ropoulou M, Dimitrakakis C. Pyoderma h ps://doi.org/10.1159/000081488 Gangrenosum of the breast: A case report study. 13. Pinto GM, Cabecas MA, Riscado M, Goncalves H. Int J Surg Case Rep. 2017;31:203–5. h ps://doi. Pyoderma gangrenosum associated with systemic org/10.1016/j.ijscr.2017.01.036 lupus erythematosus: response to pulse steroid 8. Su WP, Schroeter AL, Perry HO, Powell FC. therapy. J Am Acad Dermatol. 1991:24(5):818-21. Histopathologic and immunopathologic h ps://doi.org/10.1016/0190-9622(91)70122-I

69 NJDVL. Vol 16, No.1, 2018